Related Experiment Videos

Effects of antenatal exposure to anorectic drugs

Insights

Anorectic drug use during pregnancy did not increase overall severe congenital anomaly rates. However, amphetamine exposure in early pregnancy was linked to a higher incidence of oral clefts in offspring.

Area of Science:

  • Obstetrics and Gynecology
  • Teratology
  • Pediatric Development

Background:

  • Anorectic drugs were historically prescribed to pregnant women.
  • Concerns exist regarding the teratogenic potential of these medications.

Purpose of the Study:

  • To evaluate the teratogenicity of anorectic drugs (amphetamines, phenmetrazine) in pregnant women.
  • To assess the impact of drug exposure on severe congenital anomaly rates and specific birth defects.

Main Methods:

  • Prospective, observational study design.
  • Inclusion of a large cohort of pregnant women and their children.
  • Evaluation of drug exposure timing and congenital anomaly rates up to age five years.

Main Results:

  • No significant difference in severe congenital anomaly (SCA) rates between drug-exposed and unexposed children.
  • An increased risk of oral clefts observed in offspring whose mothers used amphetamines during the first 56 days of pregnancy.
  • Anorectic drugs demonstrated limited short-term efficacy in weight reduction.

Conclusions:

  • Overall teratogenic risk for severe congenital anomalies appears low with anorectic drug use.
  • Specific risks, such as oral clefts, are associated with early pregnancy amphetamine exposure.
  • The efficacy of anorectic drugs for weight management during pregnancy is minimal and short-lived.

Related Concept Videos